Healthcare Industry News

Learn more about the role of Hand Hygiene in Reducing Health Care-Associated Infections (HAIs) including the role of dispenser placement in maximizing usage.

Research shows that hand hygiene dispenser placements have an impact on Hand Hygiene compliance rates . To help healthcare institutions maximize positive hygiene impact, Tork has created this short video to support hospitals in dispenser placement decisions.

This June, Subaru, their retailers, and the Leukemia & Lymphoma Society (LLS) are teaming up for the Subaru Loves to Care initiative.Together, LLS and Subaru will spread hope, love, and warmth to those fighting cancer through small gestures of caring. You can show your support too! Watch to learn more.

For the second year in a row, Subaru of America and The Leukemia & Lymphoma Society (LLS) will spread love, hope and warmth to cancer patients and their families in communities across the country.

How can we prevent the urbanization boom from becoming a health crisis? Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.

On World Hypertension Day 2017, the Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure (hypertension) in low-income urban communities.

Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation. Novartis Access medicines will be made available to the poorest population in Pakistan through hospitals under the Prime Minister’s National Health Insurance Program.

What could changes in health care policy mean for the work of foundations focused on health?

Gilead Sciences, Inc. today announced that it issued its Year in Review 2016, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.